Abstract
Chronic granulomatous disease (CGD) is a phagocytic defect characterized by recurrent bacterial and fungal infections. We report clinical profile of patients with CGD and mycobacterial infections in a cohort from North India. A review of clinical and laboratory records was carried out for patients with CGD registered at our center between 1990 and 2021. Of the 99 patients with CGD, 22 had mycobacterial infections—Mycobacterium tuberculosis and M. bovis-BCG in 11 each. Among the children with M. bovis-BCG infection, 6 had localized and 5 had disseminated BCG disease. Median age at onset of symptoms and diagnosis of BCG disease was 5 months and 15 months, respectively. While disseminated forms of BCG were noted only in CYBB defect, none of the patients with NCF1 defect developed complications due to BCG vaccine. A recurring radiological feature was left axillary lymph node calcification, which was present in around 50% of CGD patients with BCG infections. Of 11 patients with tuberculosis, pulmonary, pleuro-pulmonary, abdominal, and disseminated forms were present in 6, 1, 2, and 2, respectively. Median age at onset of symptoms and diagnosis of tuberculosis was 129 months and 130 months, respectively. Molecular defects were identified in CYBB (5), NCF1 (4), and CYBA (1). Incidence of tuberculosis and BCG-related complications in patients with CGD is higher than the normal population. Screening for CGD is warranted in any patient with adverse reactions to BCG vaccination, calcification of left axillary lymph node, and persistent, recurrent or disseminated forms of tuberculosis.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Berendes H, Bridges RA, Good RA. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957 May;40(5):309–12.
Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease: report on a National Registry of 368 Patients. Medicine. 2000;79(3):155–69.
Babior BM. NADPH oxidase: an update. Blood. 1999;93(5):1464–76.
Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E, et al. Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases. J Allergy Clin Immunol. 2016;138(1):241–248.e3.
Lee PPW, Chan KW, Jiang L, Chen T, Li C, Lee TL, et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. J Pediatr Infect Dis. 2008;27(3):224–30.
Deffert C, Schäppi MG, Pache JC, Cachat J, Vesin D, Bisig R, et al. Bacillus Calmette-Guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation. Behr MA, editor. PLoSPathog. 2014;10(9):e1004325.
Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol: In Practice. 2019;7(6):1763–70.
Rawat A, Vignesh P, Sudhakar M, Sharma M, Suri D, Jindal A, et al. Clinical, immunological, and molecular profile of chronic granulomatous disease: a multi-centric study of 236 patients from India. Front Immunol. 2021;25(12):625320.
Li T, Zhou X, Ling Y, Jiang N, Ai J, Wu J, et al. Genetic and clinical profiles of disseminated bacillus Calmette-Guérin disease and chronic granulomatous disease in China. Front Immunol. 2019;29(10):73.
Ariga T, Sakiyama Y, Tomizawa K, Imajoh-Ohmi S, Kanegasaki S, Matsumoto S. A newly recognized point mutation in the cytochrome b558 heavy chain gene replacing alanine57 by glutamic acid, in a patient with cytochrome b positive X-linked chronic granulomatous disease. Eur J Pediatr. 1993;152(6):469–72.
Roos D, van Leeuwen K, Hsu AP, Priel DL, Begtrup A, Brandon R, et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells Mol Dis. 2021;90:102587.
Roos D, van Leeuwen K, Hsu AP, Priel DL, Begtrup A, Brandon R, et al. Hematologically important mutations: the autosomal forms of chronic granulomatous disease (third update). Blood Cells Mol Dis. 2021;92:102596.
Vignesh P, Sharma M, Pilania RK, Shandilya JK, Kaur A, Goel S, et al. Myriad faces of chronic granulomatous disease: all in an Indian family with novel CYBB defect. J Clin Immunol. 2019;39(6):611–5.
Kuhns DB, Hsu AP, Sun D, Lau K, Fink D, Griffith P, et al. NCF1 (p47phox)–deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis. Blood Adv. 2019;3(2):136–47.
Pilania RK, Prithvi A, Nambiyar K, Gupta K, Rawat A. Revisiting fatal granulomatous disease of childhood through an autopsy: still lethal in the developing world! J Clin Immunol. 2019;39(3):241–4.
Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011;12(3):213–21.
Lau YL, Chan GC, Ha SY, Hui YF, Yuen KY. The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis. Clin Infect Dis. 1998;26(1):226–7.
Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, BabaeiJandaghi A, Farhoudi A, et al. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian Primary Immunodeficiency Registry. Int Arch Allergy Immunol. 2004;134(3):253–9.
Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol. 2007;120(1):32–8.
Xu H, Tian W, Li SJ, Zhang LY, Liu W, Zhao Y, et al. Clinical and molecular features of 38 children with chronic granulomatous disease in Mainland China. J Clin Immunol. 2014;34(6):633–41.
Zhou Q, Hui X, Ying W, Hou J, Wang W, Liu D, et al. A cohort of 169 chronic granulomatous disease patients exposed to BCG vaccination: a retrospective study from a single center in Shanghai, China (2004–2017). J Clin Immunol. 2018;38(3):260–72.
Tajik S, Badalzadeh M, Fazlollahi MR, Houshmand M, Bazargan N, Movahedi M, et al. Genetic and molecular findings of 38 Iranian patients with chronic granulomatous disease caused by p47- phox defect. Scand J Immunol [Internet]. 2019;90(1) https://doi.org/10.1111/sji.12767.
León-Lara X, Campos-Murguía A, León-Cabral P, Tello-Mercado A, Salgado-Nesme N, de la Mora JD, et al. Disseminated tuberculosis in a patient with autosomal recessive p47phox chronic granulomatous disease. J Clin Immunol. 2021;41(6):1417–9.
Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD, et al. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol. 2011;31(5):792–801.
Bakri FG, Martel C, Khuri-Bulos N, Mahafzah A, El-Khateeb MS, Al-Wahadneh AM, et al. First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families. J Clin Immunol. 2009;29(2):215–30.
Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8(3):e1001012.
Rangesh S, Vaidya PC, Mehra N, Gupta S, Bharti B. Incidence of lymphadenitis following Bacillus Calmette-Guérin (BCG) vaccination in north Indian children. Indian J Tuberc. 2022;69(4):596–601. https://doi.org/10.1016/j.ijtb.2021.09.008.
Vaugon E, Blanchard AC, Magyar M. A 3-year-old girl with an axillary lymph node. Paediatr Child Health. 2022;27(7):389–90. https://doi.org/10.1093/pch/pxac090.
Trehan I, Mouayaxeng S, Nigogosyan MA. Axillary calcification due to bacillus Calmette-Guérin Vaccination. J Pediatr. 2020;223:218–9.
Yao Q, Zhou QH, Shen QL, Wang XC, Hu XH. Imaging characteristics of pulmonary BCG/TB infection in patients with chronic granulomatous disease. Sci Rep. 2022;12(1):11765.
Shrot S, Barkai G, Ben-Shlush A, Soudack M. BCGitis and BCGosis in children with primary immunodeficiency - imaging characteristics. PediatrRadiol. 2016;46(2):237–45.
Deffert C, Cachat J, Krause KH. Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections: NADPH oxidase and BCG infection. Cell Microbiol. 2014;16(8):1168–78.
Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, et al. Primary Immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract. 2020;8(4):1371–86.
Yadav RM, Dalvi A, Gupta M, Bargir UA, Shabrish S, Aluri J, et al. Spectrum of inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India. Scand J Immunol. 2021;93(5):e13010.
SoyakAytekin E, Keskin A, Tan C, Yalçın E, Dogru D, Ozcelik U, et al. Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: a single-centre study. Scand J Immunol. 2021;94(4):e13084.
Acknowledgements
We acknowledge the support from faculty and residents of the pediatric subspecialities in the Department of Pediatrics, Advanced Pediatric Centre, PGIMER, Chandigarh, and other departments of PGIMER, Chandigarh, that helped in the diagnosis and clinical management of the cases. We thank the junior residents of Department of Pediatrics who have assisted in the clinical management. We also thank faculty members, research fellows, and laboratory technicians of the Pediatric Immunology laboratory, Allergy Immunology Unit, Advanced Pediatrics Centre, PGIMER, Chandigarh, who have assisted in the laboratory experiments.
Funding
Dr. Pandiarajan Vignesh received funding from the Indian Council of Medical Research for the project entitled, “Evaluation of immunogenetic risk factors in children with serious forms of mycobacterial infections” (Id: 2020-9482).
Author information
Authors and Affiliations
Contributions
PV, AS, and RA were involved in conceptualization of the study design. AS, SM, and RA were involved in data collection and computation of data in excel sheet. MD, SS1, and AR helped in processing and interpretation of immunological tests. WL, SM, AS, RA, RKP, AKJ, and DS were actively involved in diagnosis and management of different cases. SS2 supervised the tests related to mycobacterial infections and interpreted the results of those tests. AS, PV, and RA wrote the manuscript. PV, AR, and SS edited the manuscript. PV and AR supervised the entire manuscript preparation.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare no competing interests.
Ethics
This study was performed in line with the principles of the Declaration of Helsinki. The Departmental Review Board of the Advanced Pediatrics Centre approved this manuscript (No. 18-23, dt. 18.03.2023).
Consent to Participate
Informed consent was obtained from the parents of the child included in this report.
Consent to Publish
All authors have given final consent for publication. Parents consented for publication of the clinical details of their child in an academic journal.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Pandiarajan Vignesh and Archan Sil are joint first authors.
Supplementary Information
Supplementary Figure 1:
BCG-vaccination site abscess formation in a child with chronic granulomatous disease. (PNG 2129 kb)
Supplementary Figure 2:
Chest radiograph showing bilateral pulmonary infiltrates (left panel). Computed tomography images of chest showing patchy areas of mosaic attenuation with ill-defined ground glass opacities are seen in bilateral lungs (right panel). (PNG 4184 kb)
Supplementary Figure 3:
Flow chart for screening of CGD in patients with mycobacterial infections. (PNG 2372 kb)
ESM 4
(DOCX 21 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Vignesh, P., Sil, A., Aggarwal, R. et al. Tuberculosis and Bacillus Calmette-Guérin Disease in Patients with Chronic Granulomatous Disease: an Experience from a Tertiary Care Center in North India. J Clin Immunol 43, 2049–2061 (2023). https://doi.org/10.1007/s10875-023-01581-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-023-01581-w